@efis-immunology.bsky.social
Non-profit organisation uniting 36 national immunology societies from Europe, Eurasia, and the Middle East and connecting nearly 14,000 researchers and clinicians working in immunology
đź”— www.efis.org
#immunology #immunosky
@efis-immunology.bsky.social@dgfi-org.bsky.social Spring School is accepting registrations until November 15th!
Great advanced intensive program targeting late stage PhD Students and early postdocs! Details 👇
@efis-immunology.bsky.social
@efis-immunology.bsky.social@immunometeurope.bsky.social @sexdiffimmunity.bsky.social @swimm-immuno.bsky.social @finnsocimm.bsky.social @fcyimmuno.bsky.social @hammarieke.bsky.social @bojanpolic.bsky.social
@efis-immunology.bsky.social@iuis-online.bsky.social @iuisjuniorcomm.bsky.social @sfi-immunologie.bsky.social @dgfi-org.bsky.social @dgfi-yi.bsky.social @ybis.bsky.social @yssi-immunology.bsky.social @yspi.bsky.social @syis-ecr.bsky.social @irishimmunology.bsky.social @britsocimm.bsky.social @nextgenimmuno.bsky.social
@efis-immunology.bsky.social📅 15 October 2026 — Abstract submission opens
📍 Florence, Italy — 5–8 September 2027
✨ Mark your calendars and follow @efis-immunology.bsky.social for the latest updates!
👉 eci2027.org
We can’t wait to see you in Florence! 🇮🇹🎉
@efis-immunology.bsky.social🚀 The wait is over — #ECI2027 is officially underway!
The road to Europe’s major immunology meeting has begun! 🔬
đź“Ł Abstract submission opens 15 October 2026!
Start preparing your latest research and get ready to share it with the immunology community in Florence. 🇮🇹🧬
@efis-immunology.bsky.social@nextgenimmuno.bsky.social @britsocimm.bsky.social @fcyimmuno.bsky.social @hammarieke.bsky.social @bojanpolic.bsky.social @eurjimmunol.bsky.social
@efis-immunology.bsky.social@yefis-immunology.bsky.social @iuis-online.bsky.social @iuisjuniorcomm.bsky.social @sfi-immunologie.bsky.social @irishimmunology.bsky.social @dgfi-org.bsky.social @swimm-immuno.bsky.social @finnsocimm.bsky.social @ybis.bsky.social @yssi-immunology.bsky.social @yspi.bsky.social @syis-ecr.bsky.social
@efis-immunology.bsky.social🎀 October is #BreastCancerAwareness Month.
🔬 #Immunology research is opening new avenues in #breastcancerresearch and treatment.
✨ Better understanding. New possibilities. Continued progress.
đź’ˇThis month, #EFIS highlights the vital role of immunology research in the fight against cancer đź’™ đź’Ş
@efis-immunology.bsky.social@yefis-immunology.bsky.social @yssi-immunology.bsky.social @ybis.bsky.social @yspi.bsky.social @fcyimmuno.bsky.social @dgfi-yi.bsky.social @dgfi-org.bsky.social @nextgenimmuno.bsky.social @sfi-immunologie.bsky.social @irishimmunology.bsky.social @syis-ecr.bsky.social
@efis-immunology.bsky.social🔬T-cell Connect Europe (TCCE), the EFIS–Immunology Letters study group, initiated the series focusing on #Tcellbiology + T cell-mediated immunity in 2020 in response to the pandemic to facilitate exchange among T-cell immunologists.
đź’ˇMonthly every 1st Tuesday at 17:00, for two talks + discussion.
@efis-immunology.bsky.social📣 T Cell Connect Europe – Online Immunology Lecture Series kicking off after summer break TODAY!
đź“… Oct 6th at 17:00
🎙️ Presenters: Taras Kreslavskiy from Karolinska Institute and Dietmar Herndler-Brandstetter from Medical University of Vienna.
đź”— For more information and zoom link: www.t-cells.eu
@nobelprize.orgReposted by @efis-immunology.bsky.socialBREAKING NEWS The 2026 Nobel Prize in Physiology or Medicine has been awarded to Karl Deisseroth, Peter Hegemann and Georg Nagel “for their discoveries concerning light-gated ion channels and optogenetics.”
@efis-immunology.bsky.social@swimm-immuno.bsky.social @finnsocimm.bsky.social @hammarieke.bsky.social @bojanpolic.bsky.social
@efis-immunology.bsky.social@yssi-immunology.bsky.social @fcyimmuno.bsky.social @nextgenimmuno.bsky.social @irishimmunology.bsky.social @sfi-immunologie.bsky.social @dgfi-org.bsky.social @britsocimm.bsky.social @iuis-online.bsky.social @iuisjuniorcomm.bsky.social @ybis.bsky.social @syis-ecr.bsky.social
@efis-immunology.bsky.social🔬 Eligible applicants must have earned their PhD (or equivalent) after 1 January 2017 + be members of an EFIS-affiliated national society.
đź“… Applications Deadline: 31 December 2026
👉 Full details & eligibility: acteriaprizes.net
@yefis-immunology.bsky.social @yspi.bsky.social @dgfi-yi.bsky.social
@efis-immunology.bsky.socialđź“Ł The 2026 #ACTERIA Early Career Research Prizes, awarded by #EFIS, are now open!
🔬 Two prizes—one in #immunology and one in #allergology -recognise outstanding researchers with up to 10 years of postdoctoral experience.
🏆 €30,000 cash award + possible research funding of €50,000/year for 3 years.
@globalimmuno.bsky.socialReposted by @efis-immunology.bsky.socialDr. Steffen Massberg’s seminar entitled “Cellular Conversations between Thrombosis and Immunity” is now available on YouTube youtube.com/live/8e0WPls...
Please ask questions in the comment section for Steffen.
Hope you enjoy it!
@costactionca24117.bsky.socialReposted by @efis-immunology.bsky.social🎓 COST Academy Training | How to Coordinate International Research Networks
On 28 September 2026, Dr Ahmet Eken, Management Committee Member of COST Action CA24117 – ILCquest, participated in the COST Academy training held in Brussels.
@yefis-immunology.bsky.socialReposted by @efis-immunology.bsky.social🚨 NIMSB PhD Fellowships Call is now open! 🇵🇹 Are you a motivated researcher looking to pursue a PhD in Lisbon, Portugal? 🧬🔬 The NOVA Institute for Medical Systems Biology (NIMSB) is offering 9 PhD fellowships👇
